ABSTRACTS
P12 DEVELOPMENT OF AN EASY-TO-USE ADAMTS13 CONFORMATION ASSAY USING FIBER OPTIC SURFACE PLASMON RESONANCE TECHNOLOGY
Dekimpe C, Bonnez Q, Roose E, Tellier E, Kaplanski G, Feys H, Tersteeg C, De Meyer S, Vanhoorelbeke K
P03 USING A ST4 MECHANICAL DEVICE AS BACK-UP FOR SIEMENS OPTICAL CS COAGULATION AUTOMATE: A PRACTICAL EXPERIENCE
Debuysschere C, Ruth I, Demulder A, Rozen L
P04 ANTITHROMBIN DEFICIENCY: LOOK BACK ON TYPE 2 HEPARIN BINDING SITE IN CHU DE CHARLEROI
Goudji C, Jochmans K, Orlando C, Stouffs K, Tamigniau A, Jurdan M, Cauchie P
P05 CASE REPORT: WHAT HAS A WASP TO DO WITH AN UNCLOTTABLE APTT?
Cuykx M, Maes M, Van Der Heijden C
P06 INVESTIGATING THE CAUSE OF “EARLY REACTION ERROR” ON APTT TEST CARRIED OUT ON PLASMAS OF ICU COVID PATIENTS USING THE CS5000 AUTOMATE
Ruth I, Debuysschere C, Demulder A, Rozen L
P07 EVALUATION OF THE BIOPHEN FVIII:C BOVINE R1 KIT FOR THE MEASUREMENT OF FACTOR VIII INHIBITORS IN HEMOPHILIA A PATIENTS TREATED WITH EMICIZUMAB
Guillaume L, Hermans C, Lambert C, Van Dietvoet M
P08 ACETYL-COA CARBOXYLASE INHIBITION ALTERS TUBULIN ACETYLATION AND AGGREGATION IN THROMBIN-STIMULATED PLATELETS
Octave M, Ginion A, Pirotton L, Robaux V, Lepropre S, Kautbally S, M. Darley-Usmar V, Ambroise J, Guigas B, Foretz M, Bertand L, Beauloye C, Horman S
P09 THE ROLE OF α1AMP-ACTIVATED PROTEIN KINASE (α1AMPK) IN HAEMOSTATIC DYSFUNCTIONS INDUCED BY SEPSIS
De Poortere J, Angé M, Castanares-Zapatero D, Bertand L, Horman S, Beauloye C
P10 MONITORING FVIII REPLACEMENT THERAPY IN A PATIENT UNDER EMICIZUMAB
Smolders D, Deiteren K, Maes M
P11 CHOLESTEROL-AND PALMITATE/OLEATE-ENRICHED DIETS INDUCE DISTINCT AORTA AND AORTIC VALVE CALCIFICATION IN RABBIT MODELS
Donis N, D'emal C, Hulin A, Gustin M, Dulgheru R, Lancellotti P, Oury C
P02 VALIDATION OF MINIMAL TUBE FILL VOLUME ON ROUTINE COAGULATION TESTS ON STAR MAX3
Ver Elst K, Janssen S, Vermeiren S, Weekx S
P13 CLINICAL EXOMES AND MENDELIOME SCREENING FOR THE DIAGNOSIS OF INHERITED BLEEDING, THROMBOTIC AND PLATELET DISORDERS USE IN A CLINICAL DIAGNOSTIC SETTING IN BELGIUM
Van Laer C, Jacquemin M, Baert S, Corveleyn A, Labarque V, Thys C, Vanassche T, Van Geet C, Van Hoof E, Peerlinck K, Freson K
P14 FROM THE ANTIPLATELET DRUG TICAGRELOR TO NEW ANTIBIOTICS
Jacques N, Goffin E, Musumeci L, Pirotte B, Lancellotti P, Oury C
P15 REAL-WORLD EXPERIENCE OF SWITCHING FROM SHL-RFIX TO EHL-RFIXFC IN MODERATE AND SEVERE HAEMOPHILIA B PATIENTS: A RETROSPECTIVE ANALYSIS FROM TWO BELGIAN CENTERS
Peerlinck K, Lambert C, Vandenbriele C, Hermans C
P16 HEAD TO HEAD COMPARISON OF COAGULATION, PLATELET ACTIVATION AND NETOSIS IN SEPTIC SHOCK AND CRITICAL COVID-19 PATIENTS ADMITTED IN THE ICU
Dechamps M, De Poortere J, Bodart J, Octave M, Laterre P, Castanares-Zapatero D, Bertand L, Horman S, Beauloye C
P17 ANTI-CYSTEINE/SPACER AUTOANTIBODIES PLAY A MAJOR ROLE IN INDUCING AN OPEN ADAMTS13 CONFORMATION IN IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
De Waele L, Curie A, Tellier E, Kaplanski G, Tersteeg C, Coppo P, Veyradier A, De Meyer S, Roose E, Vanhoorelbeke K
THROMBOPROPHYLAXIS AND COAGULOPATHY IN COVID-19
Marcel Levi
BSTH GUIDANCE OF ANTICOAGULATION IN COVID-19
Thomas Vanassche
ANTICOAGULATION IN CRITICAL CARE PATIENTS AND IN PATIENTS ON MECHANICAL CARDIOPULMONARY SUPPORT
Deepa Jayakody Arachchillage
IMMUNOTHROMBOSIS IN ACUTE RESPIRATORY DISTRESS SYNDROME
Frantzeska Frantzekaki
DIAGNOSIS OF ACUTE PULMONARY EMBOLISM
Pierre-Yves Leroux
DIAGNOSIS AND ANTITHROMBOTIC MANAGEMENT OF ACUTE PULMONARY EMBOLISM
Stavros Konstantinides
SALMONELLA-INDUCED THROMBOSIS
Adam Cunningham
NETS AT THE INTERFACE OF THROMBOSIS AND INFLAMMATION
Kim Martinod
THROMBOSIS AND HAEMOSTASIS SIXTY YEARS AGO
Jos Vermylen
O01 INHIBITION OF ADAMTS13 RESCUES ACQUIRED VON WILLEBRAND SYNDROME IN A PRECLINICAL MECHANICAL CIRCULATORY SUPPORT ANIMAL MODEL
Deconinck S, Jacobs S, Nix C, Barth S, Benneck-Schöpping E, Schelpe A, Roose E, Pareyn I, Vandenbulcke A, Meyns B, Tersteeg C, De Meyer S, Vanhoorelbeke K
O02 NEUTROPHIL EXTRACELLULAR TRAPS INFILTRATE THE LUNG AIRWAY, INTERSTITIAL, AND VASCULAR COMPARTMENTS IN SEVERE COVID-19
Radermecker C, Detrembleur N, Guiot J, Cavalier E, Henket M, D'emal C, Vanwinge C, Cataldo D, Oury C, Delvenne P, Marichal T
O03 TICAGRELOR DISRUPTS THE PHOSPHOLIPID MEMBRANE OF GRAM-POSITIVE BACTERIA
Musumeci L, Jacques N, PENOY N, Goffin E, PIEL G, Pirotte B, AMOROSO A, VERLAINE O, JORIS B, Lancellotti P, Oury C
O04 OPTIMAL ANTITHROMBOTIC REGIMEN IN PATIENTS WITH CARDIOGENIC SHOCK ON IMPELLATM MECHANICAL SUPPORT: LESS MIGHT BE MORE
Vandenbriele C, Dannenberg L, Monteagudo Vela M, Balthazar T, Metzen T, Voss F, Horn P, Westenfeld R, T. Zeus, Kelm M, Vanassche T, Verhamme P, Janssens S, Panoulas V, Price S, Polzin A
O05 DETAILED HISTOLOGICAL ANALYSIS OF ISCHEMIC STROKE THROMBI REVEALS A PLATELET-DOMINANT THROMBUS COMPOSITION IN PATIENTS WITH CARDIOEMBOLIC ETIOLOGY
Staessens S, François O, Boulleaux E, Corseaux D, Desender L, Vandenbulcke A, De Sloovere A, Dewaele T, Vanacker P, Susen S, Vanhoorelbeke K, Cordonnier C, Andersson T, De Meyer S
O06 INCIDENCE OF VENOUS THROMBOEMBOLISM AND PROPHYLACTIC STRATEGY IN PATIENTS DISCHARGED AFTER COVID-19 HOSPITALIZATION
Engelen M, Vanassche T, Balthazar T, Claeys E, Gunst J, Jacquemin M, Janssens S, Lorent N, Liesenborghs L, Peerlinck K, Pieters G, Rex S, Sinonquel P, Van Laer C, Vos R, Wauters J, Alexander W, Verhamme P, Vandenbriele C
P01 HOMOZYGOUS FACTOR V DEFICIENCY: A CASE REPORT
Goudji C, Tasiaux N, Chevalier C, Cauchie P
Top
